These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8490118)

  • 1. Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation.
    Freedman BI; Espeland MA; Heise ER; Evans J; Canzanello VJ
    J Am Soc Nephrol; 1993 Feb; 3(8):1467-73. PubMed ID: 8490118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in HLA antigen frequency and hypertensive renal failure.
    Freedman BI; Espeland MA; Heise ER; Adams PL; Buckalew VM; Canzanello VJ
    Am J Hypertens; 1991 May; 4(5 Pt 1):393-8. PubMed ID: 2069771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation.
    Freedman BI; Spray BJ; Heise ER; Espeland MA; Canzanello VJ
    Am J Kidney Dis; 1993 Apr; 21(4):378-82. PubMed ID: 8465816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis.
    Freedman BI; Spray BJ; Heise ER
    Am J Kidney Dis; 1994 Mar; 23(3):352-7. PubMed ID: 8128935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is diabetic microangiopathy genetically heterogeneous? HLA and diabetic nephropathy.
    Barbosa J
    Horm Metab Res Suppl; 1981; 11():77-80. PubMed ID: 6947952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation.
    Freedman BI; Spray BJ; Dunston GM; Heise ER
    Am J Kidney Dis; 1994 Jun; 23(6):797-802. PubMed ID: 8203361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in White and Black South African diabetics.
    Shires R; Maier G; Lustig A; Barnett P; Joffe BI; Seftel HC
    S Afr Med J; 1983 Dec; 64(28):1087-9. PubMed ID: 6582605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA associations with insulin-dependent diabetes mellitus in a sample of the American Black population.
    Reitnauer PJ; Roseman JM; Barger BO; Murphy CC; Kirk KA; Acton RT
    Tissue Antigens; 1981 Mar; 17(3):286-93. PubMed ID: 6947506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Leukocyte Antigens (HLA) Genes Association in Type 1 Diabetic Nephropathy.
    Mihoubi E; Amroun H; Raache R; Bouldjennet F; Meçabih F; Azzouz M; Boudiba A; Mahgoun S; Akachouche M; Salhi N; Touil-Boukoffa C; Abbadi MC; Attal N
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1157-1164. PubMed ID: 30806329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA phenotypes with hypertension in African Americans and Caucasoid Americans with type II diabetes, a population at risk for renal disease.
    Acton RT; Bell DS; Go RC; Roseman J; Tseng ML; Louv W
    Transplant Proc; 1993 Aug; 25(4):2400-3. PubMed ID: 8356614
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients.
    Ross W; Solomon H; Reese J; Fairchild R; Garvin P; Kurtz M
    Transplant Proc; 1993 Aug; 25(4):2408-10. PubMed ID: 8356616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of race on outcome following kidney and kidney-pancreas transplantation in type I diabetics: the South-Eastern Organ Procurement Foundation experience.
    Douzdjian V; Thacker LR; Blanton JW
    Clin Transplant; 1997 Oct; 11(5 Pt 2):470-5. PubMed ID: 9361943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HLA frequency differences in races on the access to optimally HLA-matched cadaver renal transplants. The Medical Advisory Committee.
    Lazda VA
    Transplantation; 1992 Feb; 53(2):352-7. PubMed ID: 1738929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-antigen distribution in juvenile diabetics with end-stage nephropathy.
    Pitkänen E; Kuhlbäck B; Tiilikainen A; Lokki ML; Kärkkäinen J
    Ann Clin Res; 1981 Apr; 13(2):91-5. PubMed ID: 7235615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetes.
    Chowdhury TA; Dyer PH; Mijovic CH; Dunger DB; Barnett AH; Bain SC
    Diabetologia; 1999 Aug; 42(8):1017-20. PubMed ID: 10491764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease effects and associations.
    Mitsuishi Y; Cecka JM
    Clin Transpl; 1992; ():371-81. PubMed ID: 1306713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A, B, C and DR antigen associations in insulin dependent diabetes mellitus (IDDM) in South African Negro (black) and Cape coloured people.
    Orren A; Taljaard D; de Toit E
    Tissue Antigens; 1985 Nov; 26(5):332-9. PubMed ID: 3867179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.